New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...

As entrepreneurs, we know that time is money. Wasting it on endless software development can be frustrating and costly. As the CEO of Glorium, I've helped make numerous software projects happen. Based ...

Back in 2022, I wrote about the triple threat of additive, agility and automation—three forces that were already reshaping manufacturing and product development. Fast forward to 2025, and these trends ...